A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)
- Status
- COMPLETED
- Phase
- PHASE1
Vaccination of Triple Negative Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
- Status
- TERMINATED
- Phase
- PHASE1
Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Study Of Single-dose Cyclophosphamide +Pembrolizumab In Patients With Metastatic Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Neoadjuvant Chemotherapy Docetaxel With or Without SELUMETINIB in Patients With Triple Negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Olaparib in Locally Advanced ER, PgR and HER2 Negative (Triple Negative) and in Locally Advanced Germline BRCA Mutation-positive Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Pilot Surveillance Study to Monitor Natural Killer Cells and Circulating Tumor Cells in Women With Previously Treated Non-metastatic Triple Negative Breast Cancer and Women With Previously Treated Non-metastatic Breast Cancer With a Confirmed BRCA Mutation.
- Status
- UNKNOWN
- Phase
- N/A
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast Cancers
- Status
- UNKNOWN
- Phase
- PHASE1
Huaier Granule in Treating Women With Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE4